Titlebook: Clinical Psychopharmacology for Neurologists; A Practical Guide George T. Grossberg,Laurence J. Kinsella Book 2018 Springer International P

否決

Psychopharmacology for Neurologists,e patients with mood disorders, and many are comfortable prescribing a first-line agent such as an SSRI. In fact, a majority of mood disorders are treated by non-psychiatrists. Newer data shows the high prevalence of mood disorders in neurologic disease, such as Parkinson disease, stroke, and dement

faultfinder

General Principles of Psychopharmacology,ants, antipsychotics, and mood stabilizers were discovered to have efficacy in the 1950s, considerable efforts were taken to describe the pharmacology and neurobiology of psychiatric conditions and medications. With the exponential increase in knowledge of psychotropes, clinicians have had trouble s

迷住

Abjure

Antidepressants,tidepressant medication and depression-focused psychotherapy. All antidepressants are considered equally effective; therefore most clinicians select an agent based upon its side effect and safety profile. An antidepressant must be given at its therapeutic dose for 4–6?weeks before determining whethe

PANG

Anxiolytics,e in their proper use. The mainstays of long-term treatment in any of the anxiety disorders are the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs). Acute treatment relies on benzodiazepines. Despite the effectiveness of the SSRIs and SNRIs, o

sorbitol

Sedatives and Hypnotics,of choice for decades. Benzodiazepines have shown the most evidence for effective treatment. However, they have serious side effects which include falls, confusion, rebound insomnia, tolerance, and potential for abuse. There have been newer medications that have sought to be just as effective withou

蟄伏

Treating the Behavioral Symptoms of Dementia,ficant side effects and/or paucity of data limiting evidence-based guidance for the treating physician. Non-pharmacological interventions are first-line treatment for the behavior and psychological symptoms of dementia (BPSD). However, severe mood and behavioral changes often warrant pharmacological

Critical

修飾語

Aphorism

Drug-Drug Interactions and Psychiatric Medication,has been challenging to answer, often leading to using laborious drug interaction computer programs, smartphone-based programs, or a call to the pharmacist. The purpose of this chapter is to help address this question, assess the likelihood of a drug-drug interaction, and advise the patient on what